{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:42Z","timestamp":1791267162690,"version":"4.1.0"},"reference-count":30,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swiss Study Foundation Scholarship","award":["EY019014"],"award-info":[{"award-number":["EY019014"]}]},{"name":"Janggen P\u00f6hn Foundation Scholarship","award":["EY019014"],"award-info":[{"award-number":["EY019014"]}]},{"DOI":"10.13039\/100000002","name":"Research to Prevent Blindness, the Paul and Evanina Mackall Foundation Trust and the F. M. Kirby Foundation","doi-asserted-by":"publisher","award":["EY019014"],"award-info":[{"award-number":["EY019014"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Purpose: Resveratrol is a natural polyphenol which has a very low bioavailability but whose antioxidant, anti-inflammatory and anti-apoptotic properties may have therapeutic potential for the treatment of neurodegenerative diseases such as multiple sclerosis (MS). Previously, we reported the oral administration of resveratrol nanoparticles (RNs) elicited a neuroprotective effect in an experimental autoimmune encephalomyelitis (EAE) mouse model of MS, at significantly lower doses than unconjugated resveratrol (RSV) due to enhanced bioavailability. Furthermore, we demonstrated that the intranasal administration of a cell-derived secretome-based therapy at low concentrations leads to the selective neuroprotection of the optic nerve in EAE mice. The current study sought to assess the potential selective efficacy of lower concentrations of intranasal RNs for attenuating optic nerve damage in EAE mice. Methods: EAE mice received either a daily intranasal vehicle, RNs or unconjugated resveratrol (RSV) for a period of thirty days beginning on the day of EAE induction. Mice were assessed daily for limb paralysis and weekly for visual function using the optokinetic response (OKR) by observers masked to treatment regimes. After sacrifice at day 30, spinal cords and optic nerves were stained to assess inflammation and demyelination, and retinas were immunostained to quantify retinal ganglion cell (RGC) survival. Results: Intranasal RNs significantly increased RGC survival at half the dose previously shown to be required when given orally, reducing the risk of systemic side effects associated with prolonged use. Both intranasal RSV and RN therapies enhanced RGC survival trends, however, only the effects of intranasal RNs were significant. RGC loss was prevented even in the presence of inflammatory and demyelinating changes induced by EAE in optic nerves. Conclusions: The intranasal administration of RNs is able to reduce RGC loss independent of the inflammatory and demyelinating effects on the optic nerve and the spinal cord. The concentration of RNs needed to achieve neuroprotection is lower than previously demonstrated with oral administration, suggesting intranasal drug delivery combined with nanoparticle conjugation warrants further exploration as a potential neuroprotective strategy for the treatment of optic neuritis, alone as well as in combination with glucocorticoids.<\/jats:p>","DOI":"10.3390\/ijms25074047","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T08:27:52Z","timestamp":1712305672000},"page":"4047","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Intranasal Resveratrol Nanoparticles Enhance Neuroprotection in a Model of Multiple Sclerosis"],"prefix":"10.3390","volume":"25","author":[{"given":"Ehtesham","family":"Shamsher","sequence":"first","affiliation":[{"name":"Institute of Ophthalmology, University College London, London EC1V 9EL, UK"},{"name":"Jules-Gonin Eye Hospital, Lausanne University, 1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reas S.","family":"Khan","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Institute of Ophthalmology, University College London, London EC1V 9EL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-7261","authenticated-orcid":false,"given":"Kimberly","family":"Dine","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy","family":"Luong","sequence":"additional","affiliation":[{"name":"Institute of Ophthalmology, University College London, London EC1V 9EL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-6525","authenticated-orcid":false,"given":"M. Francesca","family":"Cordeiro","sequence":"additional","affiliation":[{"name":"Institute of Ophthalmology, University College London, London EC1V 9EL, UK"},{"name":"Imperial College London Ophthalmology Research Group, London NW1 5QH, UK"},{"name":"Western Eye Hospital, London NW1 5QH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Shindler","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and Treatment of Multiple Sclerosis: A Review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Abu-Amero, K., Kondkar, A., and Chalam, K. (2016). Resveratrol and Ophthalmic Diseases. Nutrients, 8.","DOI":"10.3390\/nu8040200"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exger.2018.09.019","article-title":"Resveratrol and Alzheimer\u2019s disease. From molecular pathophysiology to clinical trials","volume":"113","author":"Drygalski","year":"2018","journal-title":"Exp. Gerontol."},{"key":"ref_4","unstructured":"Patel, R.P., Shamsher, E., Hill, D., and Cordeiro, M.F. (2020). Progress in Brain Research, Elsevier B.V."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s13311-023-01378-0","article-title":"Nanoparticles Enhance Solubility and Neuroprotective Effects of Resveratrol in Demyelinating Disease","volume":"20","author":"Shamsher","year":"2023","journal-title":"Neurotherapeutics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"41768","DOI":"10.1038\/srep41768","article-title":"Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal drug delivery: Opportunities and toxicologic challenges during drug development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.1158\/0008-5472.CAN-10-2364","article-title":"Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics, and effect on the insulin-like growth factor axis","volume":"70","author":"Brown","year":"2010","journal-title":"Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ross, A.G., Chaqour, B., McDougald, D.S., Dine, K.E., Duong, T.T., Shindler, R.E., Yue, J., Liu, T., and Shindler, K.S. (2022). Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic Neuritis. Biomolecules, 12.","DOI":"10.3390\/biom12060830"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1152\/jn.00510.2016","article-title":"Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice","volume":"116","author":"Wang","year":"2016","journal-title":"J. Neurophysiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fnins.2018.00690","article-title":"Inhibition of NF-\u03baB Signaling Pathway by Resveratrol Improves Spinal Cord Injury","volume":"12","author":"Xu","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/nyas.12819","article-title":"Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation","volume":"1348","author":"Latruffe","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s12035-016-9891-5","article-title":"Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study","volume":"54","author":"Ghaiad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/157339510791823790","article-title":"Responses of glial cells to stress and glucocorticoids","volume":"6","author":"Luquin","year":"2010","journal-title":"Curr. Immunol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Willett, K., Khan, R.S., Dine, K., Wessel, H., Kirshner, Z.Z., Sauer, J.L., Ellis, A., Brown, L.R., and Shindler, K.S. (2021). Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0243862"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Sun, B., Guo, J., and Zhou, G. (2020). Intranasal injection of recombinant human erythropoietin improves cognitive and visual impairments in chronic cerebral ischemia rats. Biomed. Rep., 13.","DOI":"10.3892\/br.2020.1347"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/bcp.13133","article-title":"Absolute bioavailability and safety of a novel rivastigmine nasal spray in healthy elderly individuals","volume":"83","author":"Morgan","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/10611860903318134","article-title":"Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS","volume":"18","author":"Lee","year":"2010","journal-title":"J. Drug Target."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102689","DOI":"10.1016\/j.nano.2023.102689","article-title":"Intranasal in situ gelling liquid crystal for delivery of resveratrol ameliorates memory and neuroinflammation in Alzheimer\u2019s disease","volume":"51","author":"Cazarin","year":"2023","journal-title":"Nanomedicine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","article-title":"Delivery of interferon-\u03b2 to the monkey nervous system following intranasal administration","volume":"152","author":"Thorne","year":"2008","journal-title":"Neuroscience"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: Mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/B978-0-08-088504-9.00180-X","article-title":"Drug Delivery across the Blood\u2013Brain Barrier","volume":"5","author":"Lalatsa","year":"2011","journal-title":"Compr. Biotechnol. Second Ed."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Beer (1852). Bestimmung der Absorption des rothen Lichts in farbigen Fl\u00fcssigkeiten. Ann. Phys., 162, 78\u201388.","DOI":"10.1002\/andp.18521620505"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1167\/iovs.18-24096","article-title":"RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome","volume":"59","author":"Grinblat","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s13311-020-00949-9","article-title":"Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis","volume":"18","author":"Khan","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/bioinformatics\/btaa847","article-title":"Colour deconvolution: Stain unmixing in histological imaging","volume":"37","author":"Landini","year":"2021","journal-title":"Bioinformatics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/cgip.1994.1037","article-title":"Utilization of Information Measure as a Means of Image Thresholding","volume":"56","author":"Shanbhag","year":"1994","journal-title":"CVGIP Graph. Model. Image Process."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Otsu, N. A threshold selection method from gray-level histograms. IEEE Trans. Syst. Man. Cybern., SMC-9, 62\u201366.","DOI":"10.1109\/TSMC.1979.4310076"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1109\/83.366472","article-title":"A new criterion for automatic multilevel thresholding","volume":"4","author":"Yen","year":"1995","journal-title":"IEEE Trans. Image Process."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/4047\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:23:42Z","timestamp":1760106222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/4047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["ijms25074047"],"URL":"https:\/\/doi.org\/10.3390\/ijms25074047","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]}}}